| scholarly article | Q13442814 |
| P356 | DOI | 10.1182/BLOOD-2005-11-4388 |
| P698 | PubMed publication ID | 16410443 |
| P2093 | author name string | Yong-Guang Yang | |
| Shumei Wang | |||
| Akira Shimizu | |||
| Ping Lan | |||
| Noriko Tonomura | |||
| P433 | issue | 2 | |
| P304 | page(s) | 487-492 | |
| P577 | publication date | 2006-01-12 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus/liver and CD34+ cell transplantation | |
| P478 | volume | 108 |
| Q93051913 | A Caulobacter crescentus Microbicide Protects from Vaginal Infection with HIV-1JR-CSF in Humanized Bone Marrow-Liver-Thymus Mice |
| Q90121995 | A Double Humanized BLT-mice Model Featuring a Stable Human-Like Gut Microbiome and Human Immune System |
| Q49990668 | A Hitchhiker's Guide to Humanized Mice: new pathways to studying viral infections. |
| Q52724272 | A Humanized Mouse Model Generated Using Surplus Neonatal Tissue. |
| Q33697336 | A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model |
| Q36969230 | A model for personalized in vivo analysis of human immune responsiveness |
| Q37664268 | A novel humanized mouse model with significant improvement of class-switched, antigen-specific antibody production |
| Q36811931 | APOBEC3G and APOBEC3F Act in Concert To Extinguish HIV-1 Replication |
| Q37342291 | Achieving tolerance in pig-to-primate xenotransplantation: reality or fantasy |
| Q36989415 | Activation of Human T Cells in Hypertension: Studies of Humanized Mice and Hypertensive Humans |
| Q57062356 | Adeno-associated virus gene delivery of broadly neutralizing antibodies as prevention and therapy against HIV-1 |
| Q59126043 | Advanced model systems and tools for basic and translational human immunology |
| Q41537754 | Alloimmune Responses of Humanized Mice to Human Pluripotent Stem Cell Therapeutics |
| Q35826239 | Alpha interferon and HIV infection cause activation of human T cells in NSG-BLT mice |
| Q35091621 | An AAV vector-mediated gene delivery approach facilitates reconstitution of functional human CD8+ T cells in mice |
| Q34039500 | An effective approach to prevent immune rejection of human ESC-derived allografts |
| Q28743012 | Analysis of the CD1 antigen presenting system in humanized SCID mice |
| Q34267776 | Animal models for viral infection and cell exhaustion |
| Q26853069 | Animal models in HIV cure research |
| Q37041160 | Animal models to achieve an HIV cure |
| Q36528798 | Antigen-specific human T-cell responses and T cell-dependent production of human antibodies in a humanized mouse model |
| Q91907826 | Antigen-specific therapeutic approaches for autoimmunity |
| Q21144657 | Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice |
| Q33652103 | Antithymocyte globulin treatment at the time of transplantation impairs donor hematopoietic stem cell engraftment |
| Q92620214 | Application of Highly Immunocompromised Mice for the Establishment of Patient-Derived Xenograft (PDX) Models |
| Q38779010 | Autologous reconstitution of human cancer and immune system in vivo. |
| Q95941885 | Autologously Humanized Mice for Immune-Oncologic Studies |
| Q35998374 | BLT humanized mice as a small animal model of HIV infection |
| Q37254470 | BLT humanized mice as model to study HIV vaginal transmission |
| Q37390234 | BLT-humanized C57BL/6 Rag2-/-γc-/-CD47-/- mice are resistant to GVHD and develop B- and T-cell immunity to HIV infection |
| Q36777155 | CD19xCD3 DART protein mediates human B-cell depletion in vivo in humanized BLT mice |
| Q37781118 | CD47 in xenograft rejection and tolerance induction |
| Q34433569 | CD8+ cell depletion accelerates HIV-1 immunopathology in humanized mice. |
| Q53140630 | Cancer stem cell definitions and terminology: the devil is in the details. |
| Q26779931 | Cancer stem cell targeted therapy: progress amid controversies. |
| Q64100649 | Cellular HIV Reservoirs and Viral Rebound from the Lymphoid Compartments of 4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine (EFdA)-Suppressed Humanized Mice |
| Q83133198 | Characterization of human B cells in umbilical cord blood-transplanted NOD/SCID mice |
| Q84040857 | Co-transplantation of fetal bone tissue facilitates the development and reconstitution in human B cells in humanized NOD/SCID/IL-2Rγnull (NSG) mice |
| Q42084230 | Comparison of human T cell repertoire generated in xenogeneic porcine and human thymus grafts |
| Q42376396 | Complement Depletion Improves Human Red Blood Cell Reconstitution in Immunodeficient Mice |
| Q90629204 | Consensus guidelines for the definition, detection and interpretation of immunogenic cell death |
| Q30664978 | Conserved and divergent aspects of human T-cell development and migration in humanized mice |
| Q30361201 | Construction of a live-attenuated HIV-1 vaccine through genetic code expansion |
| Q37049642 | Cryptopatches are essential for the development of human GALT. |
| Q34474320 | Current humanized mouse models for studying human immunology and HIV-1 immuno-pathogenesis |
| Q33596915 | Development and function of human innate immune cells in a humanized mouse model |
| Q38884521 | Development of Humanized Mice in the Age of Genome Editing. |
| Q53504782 | Development of functional human immune system with the transplantations of human fetal liver/thymus tissues and expanded hematopoietic stem cells in RAG2-/-gamma(c)-/- MICE. |
| Q98164359 | Development of the FAST-DOSE assay system for high-throughput biodosimetry and radiation triage |
| Q36984469 | Durable knockdown and protection from HIV transmission in humanized mice treated with gel-formulated CD4 aptamer-siRNA chimeras |
| Q27314724 | EBV promotes human CD8 NKT cell development |
| Q39491833 | Efficacy of broadly neutralizing monoclonal antibody PG16 in HIV-infected humanized mice |
| Q56898421 | Efficient peripheral construction of functional human regulatory CD4(+)CD25(high)Foxp3(+) T cells in NOD/SCID mice grafted with fetal human thymus/liver tissues and CD34(+) cells |
| Q27331060 | Electron tomography of HIV-1 infection in gut-associated lymphoid tissue |
| Q38926281 | Engineering Cellular Resistance to HIV-1 Infection In Vivo Using a Dual Therapeutic Lentiviral Vector |
| Q21133769 | Engineering HIV-1-resistant T-cells from short-hairpin RNA-expressing hematopoietic stem/progenitor cells in humanized BLT mice |
| Q37734869 | Entire CD3ε, δ, and γ humanized mouse to evaluate human CD3-mediated therapeutics |
| Q35252186 | Eradicating HIV-1 infection: seeking to clear a persistent pathogen |
| Q64947234 | Evaluation of the biocompatibility and stability of allogeneic tissue-engineered cartilage in humanized mice. |
| Q35691125 | Evaluation of the efficiency of human immune system reconstitution in NSG mice and NSG mice containing a human HLA.A2 transgene using hematopoietic stem cells purified from different sources |
| Q58612483 | Exploring immunomodulatory features of Mesenchymal Stromal Cells in humanized mouse models |
| Q41919588 | Exploring the Immunopathogenesis of Viral Hemorrhagic Fever in Mice with a Humanized Immune System |
| Q33911359 | Expression of HLA class II molecules in humanized NOD.Rag1KO.IL2RgcKO mice is critical for development and function of human T and B cells |
| Q33721886 | Failure of effector function of human CD8+ T Cells in NOD/SCID/JAK3⁻/⁻ immunodeficient mice transplanted with human CD34+ hematopoietic stem cells |
| Q36194261 | Full reconstitution of human platelets in humanized mice after macrophage depletion |
| Q27022347 | Gene therapy strategies for HIV/AIDS: preclinical modeling in humanized mice |
| Q35666126 | Generation of HIV latency in humanized BLT mice |
| Q37608438 | Generation of Immunodeficient Mice Bearing Human Immune Systems by the Engraftment of Hematopoietic Stem Cells |
| Q34135605 | Generation of improved humanized mouse models for human infectious diseases |
| Q91292201 | Guiding T lymphopoiesis from pluripotent stem cells by defined transcription factors |
| Q49990061 | HIV replication and latency in a humanized NSG mouse model during suppressive oral combinational ART. |
| Q37676228 | HIV-1 immunopathogenesis in humanized mouse models |
| Q35007831 | HIV-1 utilizes the CXCR4 chemokine receptor to infect multipotent hematopoietic stem and progenitor cells |
| Q37254475 | HIV-specific CD8⁺ T-cell immunity in humanized bone marrow-liver-thymus mice |
| Q39024287 | HTLV-1 Infection and Neuropathogenesis in the Context of Rag1-/-γc-/- (RAG1-Hu) and BLT Mice. |
| Q90440739 | HTLV-1 viral oncogene HBZ drives bone destruction in adult T cell leukemia |
| Q56334018 | Healthy Donor Polyclonal IgM's Diminish B Lymphocyte Autoreactivity, Enhance Treg Generation, and Reverse T1D in NOD Mice |
| Q98196708 | Highly synergistic drug combination prevents vaginal HIV infection in humanized mice |
| Q34914050 | Homeostatic expansion and phenotypic conversion of human T cells depend on peripheral interactions with APCs |
| Q33681388 | Human Cytomegalovirus Induces Cellular and Humoral Virus-specific Immune Responses in Humanized BLT Mice |
| Q52579149 | Human Immune System Mice for the Study of Human Immunodeficiency Virus-Type 1 Infection of the Central Nervous System. |
| Q98177696 | Human Thymic Involution and Aging in Humanized Mice |
| Q33995307 | Human hemato-lymphoid system mice: current use and future potential for medicine |
| Q38102807 | Human immune responses and potential for vaccine assessment in humanized mice |
| Q42254467 | Human immune system development and survival of non-obese diabetic (NOD)-scid IL2rγ(null) (NSG) mice engrafted with human thymus and autologous haematopoietic stem cells |
| Q37981545 | Human lymphohematopoietic reconstitution and immune function in immunodeficient mice receiving cotransplantation of human thymic tissue and CD34(+) cells |
| Q40043435 | Human melanoma immunotherapy using tumor antigen-specific T cells generated in humanized mice |
| Q35446761 | Human natural regulatory T cell development, suppressive function, and postthymic maturation in a humanized mouse model |
| Q89755936 | Humanization of Immunodeficient Animals for the Modeling of Transplantation, Graft Versus Host Disease and Regenerative Medicine |
| Q55190039 | Humanized Mice Engrafted With Human HSC Only or HSC and Thymus Support Comparable HIV-1 Replication, Immunopathology, and Responses to ART and Immune Therapy. |
| Q61800042 | Humanized Mice Reveal New Insights Into the Thymic Selection of Human Autoreactive CD8 T Cells |
| Q50146682 | Humanized Mice as Unique Tools for Human-Specific Studies |
| Q92881586 | Humanized Mice for Live-Attenuated Vaccine Research: From Unmet Potential to New Promises |
| Q42560779 | Humanized Mice--A Neoteric Animal Disease Model for Ebola Virus? |
| Q92177909 | Humanized Mouse Model of HIV-1 Latency with Enrichment of Latent Virus in PD-1+ and TIGIT+ CD4 T Cells |
| Q39459609 | Humanized Mouse Models for Human Immunodeficiency Virus Infection. |
| Q38640208 | Humanized Mouse Models for Transplant Immunology |
| Q59350579 | Humanized Mouse Models for the Study of Infection and Pathogenesis of Human Viruses |
| Q37614202 | Humanized Mouse Models of Clinical Disease |
| Q64228779 | Humanized Mouse Models of Rheumatoid Arthritis for Studies on Immunopathogenesis and Preclinical Testing of Cell-Based Therapies |
| Q33634034 | Humanized Mouse Models of Staphylococcus aureus Infection. |
| Q26771440 | Humanized hemato-lymphoid system mice |
| Q38838864 | Humanized mice for HIV and AIDS research |
| Q35027512 | Humanized mice for studying human leukocyte integrins in vivo |
| Q37179146 | Humanized mice for the study of infectious diseases |
| Q55039176 | Humanized mice reveal an essential role for human hepatocytes in the development of the liver immune system. |
| Q46145863 | Humanized mouse model for assessing the human immune response to xenogeneic and allogeneic decellularized biomaterials. |
| Q37089865 | Humanized mouse models of HIV infection |
| Q36142747 | Humanized mouse models of human cytomegalovirus infection |
| Q52634041 | Humanizing the mouse immune system to study splanchnic organ inflammation. |
| Q43041962 | Humoral immune responses in humanized BLT mice immunized with West Nile virus and HIV-1 envelope proteins are largely mediated via human CD5+ B cells |
| Q37254488 | Humoral immunity in humanized mice: a work in progress |
| Q59349136 | Hypercholesterolemia induces T cell expansion in humanized immune mice |
| Q35291397 | Hypogammaglobulinemia in BLT humanized mice--an animal model of primary antibody deficiency. |
| Q36972070 | IL-2 receptor γ-chain molecule is critical for intestinal T-cell reconstitution in humanized mice |
| Q89137790 | IXA Honorary Member Lecture, 2017: The long and winding road to tolerance |
| Q27692578 | Immune reconstitution of the female reproductive tract of humanized BLT mice and their susceptibility to human immunodeficiency virus infection |
| Q92376487 | Immunization of BLT Humanized Mice Redirects T Cell Responses to Gag and Reduces Acute HIV-1 Viremia |
| Q35765555 | Immunodeficient mouse model for human hematopoietic stem cell engraftment and immune system development |
| Q37467601 | Improved B cell development in humanized NOD-scid IL2Rγnull mice transgenically expressing human stem cell factor, granulocyte-macrophage colony-stimulating factor and interleukin-3 |
| Q39315707 | In Vivo Models of Human Immunodeficiency Virus Persistence and Cure Strategies |
| Q35848314 | In vivo analysis of Nef's role in HIV-1 replication, systemic T cell activation and CD4(+) T cell loss |
| Q30009533 | In vivo analysis of highly conserved Nef activities in HIV-1 replication and pathogenesis |
| Q36515119 | In vivo platforms for analysis of HIV persistence and eradication |
| Q36651190 | Increasing hematopoietic stem cell yield to develop mice with human immune systems |
| Q37363576 | Induction of human T-cell tolerance to pig xenoantigens via thymus transplantation in mice with an established human immune system |
| Q37247943 | Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT mice |
| Q39134077 | Influence of human myasthenia gravis thymus on the differentiation of human cord blood stem cells in SCID mice |
| Q89460612 | Intra-bone Bone Marrow Transplantation in Pig-to-Nonhuman Primates for the Induction of Tolerance Across Xenogeneic Barriers |
| Q92366030 | Long-term survival and differentiation of human thymocytes in human thymus-grafted immunodeficient mice |
| Q37682792 | Longitudinal imaging of HIV-1 spread in humanized mice with parallel 3D immunofluorescence and electron tomography |
| Q35585979 | Macrophages prevent human red blood cell reconstitution in immunodeficient mice |
| Q35040650 | Modeling EBV infection and pathogenesis in new-generation humanized mice |
| Q50054545 | Modeling Human Antitumor Responses In Vivo Using Umbilical Cord Blood-Engrafted Mice |
| Q37221363 | Modeling Human Leukemia Immunotherapy in Humanized Mice |
| Q64907480 | Modeling anti-CD19 CAR T cell therapy in humanized mice with human immunity and autologous leukemia. |
| Q36879075 | Modulation of human allogeneic and syngeneic pluripotent stem cells and immunological implications for transplantation |
| Q88885438 | Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells |
| Q34590684 | Mouse models with human immunity and their application in biomedical research |
| Q91813244 | Moving beyond the mousetrap: current and emerging humanized mouse and rat models for investigating prevention and cure strategies against HIV infection and associated pathologies |
| Q36923075 | Mucosal HIV-1 transmission and prevention strategies in BLT humanized mice |
| Q47151028 | Multidimensional Analysis Integrating Human T-Cell Signatures in Lymphatic Tissues with Sex of Humanized Mice for Prediction of Responses after Dendritic Cell Immunization |
| Q26823568 | Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all |
| Q36112824 | Nef functions in BLT mice to enhance HIV-1 replication and deplete CD4+CD8+ thymocytes. |
| Q98896077 | Negative selection of human T cells recognizing a naturally-expressed tissue-restricted antigen in the human thymus |
| Q27014786 | New generation humanized mice for virus research: comparative aspects and future prospects |
| Q37337138 | No irradiation required: The future of humanized immune system modeling in murine hosts |
| Q33898447 | Novel approaches for immune reconstitution and adaptive immune modeling with human pluripotent stem cells |
| Q37084504 | Novel humanized murine models for HIV research |
| Q35140303 | One percent tenofovir applied topically to humanized BLT mice and used according to the CAPRISA 004 experimental design demonstrates partial protection from vaginal HIV infection, validating the BLT model for evaluation of new microbicide candidates |
| Q35035610 | PD-1 blockade in chronically HIV-1-infected humanized mice suppresses viral loads |
| Q58770106 | Potential Pitfalls of the Humanized Mice in Modeling Sepsis |
| Q97884890 | Preclinical models of head and neck squamous cell carcinoma for a basic understanding of cancer biology and its translation into efficient therapies |
| Q40062702 | Prevention of vaginal and rectal HIV transmission by antiretroviral combinations in humanized mice |
| Q89492422 | Production of Humanized Mice through Stem Cell Transfer |
| Q33766637 | Production of bone marrow, liver, thymus (BLT) humanized mice on the C57BL/6 Rag2(-/-)γc(-/-)CD47(-/-) background |
| Q38409791 | Propagating Humanized BLT Mice for the Study of Human Immunology and Immunotherapy |
| Q47103891 | Prospects for combined use of oncolytic viruses and CAR T-cells |
| Q53837345 | Protection Efficacy of C5A Against Vaginal and Rectal HIV Challenges in Humanized Mice. |
| Q33730699 | RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice |
| Q36936058 | Rapid evolution of HIV-1 to functional CD8⁺ T cell responses in humanized BLT mice |
| Q92543466 | Recent Advances in Allergy Research Using Humanized Mice |
| Q37254480 | Recent advances in humanized mice: accelerating the development of an HIV vaccine |
| Q28488527 | Rectal transmission of transmitted/founder HIV-1 is efficiently prevented by topical 1% tenofovir in BLT humanized mice |
| Q90359789 | Reduced positive selection of a human TCR in a swine thymus using a humanized mouse model for xenotolerance induction |
| Q37600607 | Renaissance for mouse models of human hematopoiesis and immunobiology |
| Q91752345 | SIV progenitor evolution toward HIV: A humanized mouse surrogate model for SIVsm adaptation toward HIV-2 |
| Q90430180 | SIVcpz cross-species transmission and viral evolution toward HIV-1 in a humanized mouse model |
| Q42591008 | Single amino acid change in gp41 region of HIV-1 alters bystander apoptosis and CD4 decline in humanized mice |
| Q40616678 | Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model |
| Q26849806 | Studies of retroviral infection in humanized mice |
| Q35154146 | Superior human leukocyte reconstitution and susceptibility to vaginal HIV transmission in humanized NOD-scid IL-2Rγ(-/-) (NSG) BLT mice. |
| Q28472590 | Systemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT mice |
| Q92008485 | T Lymphocyte Development and Activation in Humanized Mouse Model |
| Q64991307 | TLR3 agonist and CD40-targeting vaccination induces immune responses and reduces HIV-1 reservoirs. |
| Q40734424 | Th1 and Th17 immunocompetence in humanized NOD/SCID/IL2rgammanull mice |
| Q93084382 | The Preconditioning of Busulfan Promotes Efficiency of Human CD133+ Cells Engraftment in NOD Shi-SCID IL2Rγcnull (NOG) Mice via Intra-Bone Marrow Injection |
| Q55078034 | The Use of the Humanized Mouse Model in Gene Therapy and Immunotherapy for HIV and Cancer. |
| Q61800463 | The inhibitor apoptosis protein antagonist Debio 1143 Is an attractive HIV-1 latency reversal candidate |
| Q92914944 | The inhibitor of apoptosis proteins antagonist Debio 1143 promotes the PD-1 blockade-mediated HIV load reduction in blood and tissues of humanized mice |
| Q34175149 | The use of BLT humanized mice to investigate the immune reconstitution of the gastrointestinal tract |
| Q54244413 | The use of humanized mice for studies of viral pathogenesis and immunity. |
| Q47152294 | Tolerance in xenotransplantation |
| Q50055147 | Transcription factor Hoxb5 reprograms B cells into functional T lymphocytes. |
| Q47569628 | Type 1 diabetes induction in humanized mice. |
| Q52647754 | Ultra-Sensitive HIV-1 Latency Viral Outgrowth Assays Using Humanized Mice. |
| Q92092011 | Upregulation of SLAMF3 on human T cells is induced by palmitic acid through the STAT5-PI3K/Akt pathway and features the chronic inflammatory profiles of type 2 diabetes |
| Q35738486 | Use of Humanized Mice to Study the Pathogenesis of Autoimmune and Inflammatory Diseases |
| Q36185583 | XactMice: humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer |
| Q37137178 | Xenotransplantation as a model of integrated, multidisciplinary research |
| Q36850147 | Xenotransplantation: current status and a perspective on the future |
| Q47197092 | Zika viral infection and neutralizing human antibody response in a BLT humanized mouse model |
| Q86848619 | [Development of immunodeficient mice/humanized mouse models and their applications in hematology research] |
Search more.